论文部分内容阅读
为了增加脑瘤病人的存活率,西奈山医学院的两名研究人员研究使脑更易接受的化学治疗方法. 肿瘤病讲师Mel Spigelman和神经外科医生Russ Zappulla最近开始对人进行试验打开或改变血脑屏障的方法,血脑屏障能防止毒性化学物质进入中枢神经系统。一旦此屏障被打开,就可以给予平时不能完全通过屏障的化疗药物使肿瘤缩小。大部分脑肿瘤都躲避了治疗药物的作用。每年有15,000多名美国人患脑或脑和脊髓的恶性肿瘤脑肿瘤病人的平均存活时间是6个月到一年。
To increase the survival rate of patients with brain tumors, two researchers at Mount Sinai School of Medicine studied ways to make the brain more accessible. Chemist Lecturer Mel Spigelman and neurosurgeon Russ Zappulla recently began testing people to open or change blood brains. The barrier method, the blood-brain barrier, prevents toxic chemicals from entering the central nervous system. Once this barrier is opened, tumors can be reduced by chemotherapeutic drugs that do not normally pass through the barrier. Most brain tumors escape the effects of therapeutic drugs. Every year, more than 15,000 Americans with brain or brain and spinal cord malignancy tumors have a mean survival time of 6 months to one year.